As of 2025-11-03, the Relative Valuation of Cue Biopharma Inc (CUE) is (7.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.77 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1118.7%.
The range of the Relative Valuation is (6.28) - (8.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 17.3x | 15.5x |
| Forward P/E multiples | 12.0x - 18.8x | 15.4x |
| Fair Price | (6.28) - (8.74) | (7.82) |
| Upside | -917.6% - -1238.0% | -1118.7% |
| Date | P/E |
| 2025-10-30 | -1.38 |
| 2025-10-29 | -1.36 |
| 2025-10-28 | -1.46 |
| 2025-10-27 | -1.52 |
| 2025-10-24 | -1.55 |
| 2025-10-23 | -1.54 |
| 2025-10-22 | -1.51 |
| 2025-10-21 | -1.63 |
| 2025-10-20 | -1.62 |
| 2025-10-17 | -1.57 |
| 2025-10-16 | -1.56 |
| 2025-10-15 | -1.55 |
| 2025-10-14 | -1.58 |
| 2025-10-13 | -1.61 |
| 2025-10-10 | -1.57 |
| 2025-10-09 | -1.83 |
| 2025-10-08 | -1.70 |
| 2025-10-07 | -1.49 |
| 2025-10-06 | -1.44 |
| 2025-10-03 | -1.44 |
| 2025-10-02 | -1.42 |
| 2025-10-01 | -1.43 |
| 2025-09-30 | -1.42 |
| 2025-09-29 | -1.42 |
| 2025-09-26 | -1.40 |
| 2025-09-25 | -1.36 |
| 2025-09-24 | -1.40 |
| 2025-09-23 | -1.40 |
| 2025-09-22 | -1.39 |
| 2025-09-19 | -1.33 |
| 2025-09-18 | -1.44 |
| 2025-09-17 | -1.43 |
| 2025-09-16 | -1.47 |
| 2025-09-15 | -1.46 |
| 2025-09-12 | -1.47 |
| 2025-09-11 | -1.51 |
| 2025-09-10 | -1.51 |
| 2025-09-09 | -1.52 |
| 2025-09-08 | -1.54 |
| 2025-09-05 | -1.54 |
| 2025-09-04 | -1.55 |
| 2025-09-03 | -1.57 |
| 2025-09-02 | -1.57 |
| 2025-08-29 | -1.54 |
| 2025-08-28 | -1.58 |
| 2025-08-27 | -1.63 |
| 2025-08-26 | -1.66 |
| 2025-08-25 | -1.62 |
| 2025-08-22 | -1.63 |
| 2025-08-21 | -1.60 |